Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 450 publications that have utilized our technology.

All Ageing Bioinformatics Cancer Cardiovascular diseases Drug development Fatty liver disease Gut microbiota Human genetics Kidney disease Maternal health Metabolic risk factors Method description Neurological diseases Nutrition T1D T2D Inflammation
Nightingale Health Biobank Collaborative Group, medRxiv, 2023
Zhuang et al. J Clin Endocrinol Metab. 2023
Xu et al. Nature. 2023